| 臺大學術典藏 |
2021-07-03T03:33:47Z |
Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients
|
Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S. |
| 國立臺灣科技大學 |
1992 |
PEG-SIPM-FA化合物之合成及其界面活性之研究
|
蕭耿嵩 |
| 國立臺灣科技大學 |
1997 |
PEG-SIPM界面活性劑之合成及其性質之研究
|
姜忠佑 |
| 臺大學術典藏 |
2020-02-26T01:33:46Z |
Peg-type transducer for tension measurement of an intact tendon or ligament in open repair surgery
|
Jaw, F.-S.; Lu, P.-L.; Hung, C.-Y.; Tseng, Y.-L.; Lin, C.-M.; Wang, J.-H.; FU-SHAN JAW |
| 淡江大學 |
2003-12-18 |
PEG/PLLA摻合體氧化裂解之研究
|
吳容銘 |
| 亞東技術學院 |
2010-05-27 |
PEGAE 型陽離子界面活性劑合成及對纖維素纖維染色性之研究
|
李承書 |
| 國立臺灣科技大學 |
2013 |
PEGAS: Partitioned GTS allocation scheme for IEEE 802.15.4 networks
|
Al Rasyid, M.U.H.;Lee, B.-H.;Sudarsono, A. |
| 朝陽科技大學 |
2009-04-24 |
PEGASIS架構之長存活期無線感測網路之鏈結頭選擇
|
戴良峻;黃永發;林仁勇; Yung-Fa Huang |
| 臺大學術典藏 |
2021-09-04T05:16:56Z |
Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data
|
Pavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C. |
| 國立臺灣大學 |
2004 |
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with Hbeag-Negative Chronic Hepatitis B
|
賴明陽; PATRICK MARCELLIN; LAU, GEORGE K .K.; FERRUCCIO BONINO; PATRIZIA FARCI; STEPHANOS HADZIYANNIS; JIN RUI; LU, ZHI-MENG; TEERHA PIRATVISUTH; GEORGIOS GERMANIDIS; CIHAN YURDAYDIN; MOISES DIAGO; SELIM GURE; LAI, MING-YANG |
| 國立臺灣大學 |
2007 |
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in Hcv
|
劉振驊; 陳定信; 高嘉宏; LIU, CHEN-HUA; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T06:40:18Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]
|
Liu, C.-H. and Chen, D.-S. and Kao, J.-H.; CHEN-HUA LIU |
| 臺大學術典藏 |
2021-05-24T07:20:56Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]
|
CHEN-HUA LIU; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:38Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]
|
Liu C.-H.; Chen D.-S.; JIA-HORNG KAO |
| 國立臺灣大學 |
2007-11 |
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV.
|
Liu, CH; Chen, DS; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:14:05Z |
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV.
|
CHEN-HUA LIU; CHEN-HUA LIU |
| 國立臺灣大學 |
2000 |
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
|
賴明陽; LAI, MING-YANG |
| 國立成功大學 |
2014-06-17 |
Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response
|
Tseng, Chih-Wei; Chen, Chi-Yi; Chang, Ting-Tsung; Tzeng, Shinn-Jia; Hsieh, Yu-Hsi; Hung, Tsung-Hsing; Lee, Ching-Chih; Wu, Shu-Fen; Tseng, Kuo-Chih |
| 國立臺灣大學 |
2012 |
Peginterferon alfa-2a plus Low Dose Ribavirin versus Peginterferon alfa-2a Monotherapy for Dialysis Patients with Hepatitis C Virus Genotype 1 Infection: A Randomized Trial
|
Liu, Chen-Hua; Liang, Cheng-Chao; Su, Tung-Hung; Hung, Peir-Haur; Tsai, Hung-Bin; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲 |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu, Chun-Jen;Chuang, Wan-Long;Lee, Chuan-Mo;Yu, Ming-Lung;Lu, Sheng-Nan;Wu, Shun-Sheng;Chen, Chi-Ling;Yang, Sien-Sing;Kao, Jia-Horng;Liu, Chen-Hua;Su, Wei-Wen;Jeng, Yung-Ming;Chen, Pei-Jer;Chen, Ding-Shinn; CHUN-JEN LIU; YUNG-MING JENG; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 臺大學術典藏 |
2020-03-06T08:25:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; YUNG-MING JENG; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
CHEN-HUA LIU; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2022-01-24T09:32:02Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
CHUN-JEN LIU; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2022-01-25T05:10:37Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
